spacer
home > pmps > spring 2017 > manufacturing a renaissance
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Manufacturing a Renaissance

The pharmaceutical industry is proud of its technical innovations in the discovery and development of new medicines, and rightly so – for example, the discovery of penicillin and its development as a drug product revolutionised the treatment of infectious diseases. But the pharma industry has sadly fallen far behind in product manufacturing efficiency and innovation. The polymer and foods sectors especially are constantly driving continuous improvement in manufacturing efficiencies, whereas pharma manufacturing practices have not changed significantly in fifty years.

This inertia has been attributed to constraints by regulatory agencies in what are deemed acceptable manufacturing and quality control practices. Batch processing continues to be the normal practice for medicinal products, due to the visibility and control over quality critical factors such as ingredient lots used and processing parameters. However, things are changing.

Implementation of Quality by Design (QbD) principles in product development is resulting in greater emphasis being placed on demonstrating process control through the monitoring of critical process parameters to confirm satisfactory product quality, instead of relying on the traditional approach of the testing of stratified samples. This approach is now considered as ‘best practice’ by regulatory agencies.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

spacer
Robert Harris
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Healthera Launches Digital Health Management Platform

Digital health management company announces the launch of its Health Management App
More info >>

White Papers

High Containment FIBCs Offer a Safe and Cost Effective Alternative to their Rigid Counterparts

ILC Dover

As the need for powder containment and manufacturing in accordance with cGMP standards has grown over the years, companies have sought new alternatives to rigid IBCs. Recently high containment Flexible Intermediate Bulk Containers (FIBCs) have emerged which offer an alternative that provides both powder containment and the benefits of shipping with flexibles.
More info >>

 
Industry Events

BioProcess International Conference & Exhibition (BPI)

25-28 September 2017, Hynes Convention Center, Boston, Massachusetts, USA

BioProcess International Conference & Exhibition (BPI) is the largest bioprocessing event bringing you the science, technologies and partners needed to accelerate promising biologics towards commercial success.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement